Diagnostic Biochips
Glen Burnie, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into Diagnostic Biochips
350 people in our graph share verified history with the Diagnostic Biochips team — schools, employers, funds. One of them is your warm intro.
Dougunlockedknows Brian Jamieson · together at Yale University (overlapped)
knows the team · via University of Wisconsin-Madison
×2knows the team · via University of Michigan
×4knows the team · via Yale University
×3knows the team · via NASA Goddard Space Flight Center
knows the team · via United States Olympic & Paralympic Committee
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
Founders & leadership
Diagnostic Biochips was founded in 2012 by Brian Jamieson.
BJ
Brian JamiesoninFounder & CEOBrian Jamieson is founder and CEO of Diagnostic Biochips, which develops multichannel neural probes for extracellular recording and cloud-based software for spike sorting in neuroscience research.
FW
Fan WuinCTO & VP Product DevelopmentHe joined Diagnostic Biochips in 2016 and spent nearly a decade as vice president of product development before moving into the CTO role in 2025. He also worked as a process engineer at SB Microsystems and conducted graduate and postdoctoral research at the University of Michigan.
RS
Robert Seaton CollinsNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2017–2021
▶$1.1MraisedMar 2021 · 17 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter W. Buckley, IIIDirector
- Robert E. Keith, Jr.Director
- Greg AldenExecutive Officer, Director
- Brian Glenn JamiesonExecutive Officer, Director
- Robert Seaton CollinsDirector
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04, 06b
▶$75KraisedOct 2017 · 1 investors · BiotechnologyRule 506(b)
▶$75KraisedOct 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert Seaton CollinsExecutive Officer, Director
- Brian Glenn JamiesonExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $75K
- Minimum investment
- $10K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
BioChip Labs6 shared keywordsBioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.
Molecular Devices5 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
Revvity5 shared keywordsRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Imec Int4 shared keywordsImec is an independent research and innovation center for nanoelectronics and digital technology, operating semiconductor pilot lines, cleanrooms, and labs used by industrial partners, startups, and universities. It conducts chip design and process R&D applied to fields such as health, automotive, agritech, and energy, working in an open innovation model with the global microchip value chain.
Companies competing with Diagnostic Biochips for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $886K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $772.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $636.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $266.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Diagnostic Biochips do?
- Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
- Who founded Diagnostic Biochips?
- Diagnostic Biochips was founded by Brian Jamieson in 2012.
- Who are Diagnostic Biochips's investors?
- Diagnostic Biochips's investors include TEDCO.
- How much funding has Diagnostic Biochips raised?
- Diagnostic Biochips has disclosed $1.2M raised across 2 rounds.
- Where is Diagnostic Biochips headquartered?
- Diagnostic Biochips is headquartered in Glen Burnie, US.